Abstract
The availability of monoclonal antibodies has revived interest in immunotherapy. The ability to influence an individual's immune state by administering immunoglobulin of the appropriate specificity may provide a powerful approach to disease control and prevention. Compared with immunoglobulin from other species, human immunoglobulin (Ig) might be best for such therapeutic intervention; it might function better with the recipient's effector cells and should itself be less immunogenic. The success of the mouse hybridoma system suggests that immunoglobulin of virtually any specificity can be obtained from a properly immunized animal. In the human system, however, immunization protocols are restricted by ethical considerations, and it is not yet clear whether human antibody-producing cell lines of the required specificity can be obtained from adventitiously immunized individuals or from in vitro immunized cells. A method which might circumvent these difficulties is to produce antibodies consisting of mouse variable regions joined to human constant regions. Therefore, we have constructed immunoglobulin genes in which the DNA segments encoding mouse variable regions specific for the hapten trinitrophenyl (TNP) are joined to segments encoding human μ and κ constant regions. These ‘chimaeric’ genes are expressed as functional TNP-binding chimaeric IgM. We report here some of the properties of this novel IgM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Köhler, G. & Milstein, C. Eur. J. Immun. 6, 511–519 (1976).
Hawley, R. G., Shulman, M. J., Murialdo, H., Gibson, D. M. & Hozumi, N. Proc. natn. Acad. Sci. U.S.A. 79, 7425–7429 (1982).
Ochi, A. et al. Proc. natn. Acad. Sci. U.S.A. 80, 6351–6355 (1983).
Rabbitts, T. H., Forster, A. & Milstein, C. P. Nucleic Acids Res. 9, 4509–4524 (1981).
Hieter, P. A., Max, E. E., Seidman, J. G., Maizel, J. V. & Leder, P. Cell 22, 197–207 (1980).
Southern, P. J. & Berg, P. J. molec. appl. Genet. 1, 327–341 (1982).
Ochi, A., Hawley, R. G., Shulman, M. J. & Hozumi, N. Nature 302, 340–342 (1983).
Schaffner, W. Proc. natn. Acad. Sci. U.S.A. 77, 2163–2167 (1980).
Sandri-Goldin, R. M., Goldin, A. L., Levine, M. & Glorioso, J. C. Molec. cell. Biol. 1, 743–752 (1981).
Shulman, M. J., Wilde, C. & Kohler, G. Nature 276, 269–270 (1978).
Wigler, M. et al. Cell 16, 777–785 (1979).
Rassoulzadegan, M. et al. Nature 300, 713–718 (1982).
Mulligan, R. C. & Berg, P. Proc. natn. Acad. Sci. U.S.A. 78, 2072–2076 (1981).
Shulman, M. J. et al. Can. J. Biochem. Cell Biol. 62, 217–224 (1984).
Kabat, E. A., Wu, T. T., Bilofsky, H., Reid-Miller, M. & Perry, H. Sequence of Proteins of Immunological Interest (NIH, Bethesda, Maryland, 1983).
Amsel, L. M. & Poljak, R. J. A. Rev. Biochem. 48, 961–997 (1979).
Goding, J. & Layton, J. J. exp. Med. 144, 852–857 (1976).
Neuberger, M. S. & Rajewsky, K. Proc. natn. Acad. Sci. U.S.A. 78, 1138–1142 (1981).
Oi, V. T. et al. Nature 307, 136–140 (1984).
Sharon, J. et al. Nature 309, 364–367 (1984).
Rajewsky, K. & Takemori, T. A. Rev. Immun. 1, 569 (1983).
Levy, R. & Miller, R. A. A. Rev. Med. 34, 107–116 (1983).
Shulman, M. J., Heusser, C., Filkin, C. & Kohler, G. Molec. cell. Biol. 2, 1033–1044 (1982).
Haimovich, J. & Sela, M. J. Immun. 103, 45–55 (1969).
Adams, M. H. Bacteriophages (Interscience, New York, 1959).
Williams, C. A. & Chase, M. W. Methods in Immunology and Immunochemistry Vol. 4 (Academic, New York, 1977).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boulianne, G., Hozumi, N. & Shulman, M. Production of functional chimaeric mouse/human antibody. Nature 312, 643–646 (1984). https://doi.org/10.1038/312643a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/312643a0
This article is cited by
-
Non-specificity as the sticky problem in therapeutic antibody development
Nature Reviews Chemistry (2022)
-
Hybridoma technology; advancements, clinical significance, and future aspects
Journal of Genetic Engineering and Biotechnology (2021)
-
Comparing proteins and nucleic acids for next-generation biomolecular engineering
Nature Reviews Chemistry (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.